Literature DB >> 7759394

Transfer of macrolide-lincosamide-streptogramin B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn5398.

P Mullany1, M Wilks, S Tabaqchali.   

Abstract

An MLS resistance gene designated ermBZ, from a toxigenic Clostridium difficile strain (630) could be transferred between C. difficile strains, and to and from Bacillus subtilis. The intergeneric transfer occurred in the absence of any detectable plasmid DNA and the element responsible for gene transfer entered the recipient's chromosome, behaviour which is characteristic of a conjugative transposon. The element was designated Tn5398 and was found in six C. difficile strains. Tn5398 could be transferred to the non-toxigenic strain C. difficile CD37 which lacks the genes for toxins A and B. Transconjugants from both C. difficile and B. subtilis that had received the ermBZ gene also acquired a sequence of DNA that was homologous to the part of the toxin A gene that coded for the C-terminal repeat region.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759394     DOI: 10.1093/jac/35.2.305

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  21 in total

1.  Characterization of the 13-kilobase ermF region of the Bacteroides conjugative transposon CTnDOT.

Authors:  G Whittle; B D Hund; N B Shoemaker; A A Salyers
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

2.  Homing of a group II intron from Lactococcus lactis subsp. lactis ML3.

Authors:  D A Mills; D A Manias; L L McKay; G M Dunny
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

Review 3.  Antibiotic usage in animals: impact on bacterial resistance and public health.

Authors:  A E van den Bogaard; E E Stobberingh
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

Review 4.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

5.  Immunogenicity and protective efficacy of Clostridium difficile spore proteins.

Authors:  Chandrabali Ghose; Ioannis Eugenis; Adrianne N Edwards; Xingmin Sun; Shonna M McBride; David D Ho
Journal:  Anaerobe       Date:  2015-12-11       Impact factor: 3.331

Review 6.  Diversity and Evolution in the Genome of Clostridium difficile.

Authors:  Daniel R Knight; Briony Elliott; Barbara J Chang; Timothy T Perkins; Thomas V Riley
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

7.  Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan.

Authors:  H Kato; N Kato; K Watanabe; T Yamamoto; K Suzuki; S Ishigo; S Kunihiro; I Nakamura; G E Killgore; S Nakamura
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

8.  Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.

Authors:  Renate J van den Berg; Eric C J Claas; Duddy H Oyib; Corné H W Klaassen; Lenie Dijkshoorn; Jon S Brazier; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Integration of erm(B)-containing elements through large chromosome fragment exchange in Clostridium difficile.

Authors:  François Wasels; Patrizia Spigaglia; Fabrizio Barbanti; Marc Monot; Laura Villa; Bruno Dupuy; Alessandra Carattoli; Paola Mastrantonio
Journal:  Mob Genet Elements       Date:  2015-02-03

10.  Recent emergence of an epidemic clindamycin-resistant clone of Clostridium difficile among Polish patients with C. difficile-associated diarrhea.

Authors:  Hanna Pituch; Alex Van Belkum; Nicole Van Den Braak; Piotr Obuch-Woszczatynski; Henri Verbrugh; Felicja Meisel-Mikołajczyk; Mirosław uczak
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.